The Omics-Driven Machine Learning Path to Cost-Effective Precision Medicine in Chronic Kidney Disease

Area of Science:

• Nephrology
• Bioinformatics
• Computational Biology

Background:

• Chronic kidney disease (CKD) is a major global health issue with diagnostic limitations.
• Current methods like glomerular filtration rate and proteinuria lack comprehensive insights into CKD complexity.
• Omics technologies reveal molecular mechanisms, aiding biomarker identification for CKD assessment.

Purpose of the Study:

• To provide a comprehensive overview of translating omics data into personalized CKD treatment.
• To highlight the role of artificial intelligence (AI) and machine learning (ML) in advancing CKD care.
• To emphasize the need for clinical validation of AI-driven discoveries in CKD.

Main Methods:

• Review of recent advances in omics research for CKD.
• Analysis of AI and ML applications in biomarker discovery, early diagnosis, and risk prediction for CKD.
• Discussion on integrating multi-omics datasets for patient-specific insights and decision support.

Main Results:

• Omics technologies provide deeper insights into CKD molecular mechanisms.
• AI and ML can enhance early CKD detection, risk stratification, and personalized treatment strategies.
• Integration of multi-omics data with AI offers real-time, patient-specific clinical decision support.

Conclusions:

• AI and omics integration hold significant potential to transform CKD diagnosis and management.
• Multidisciplinary collaboration and advanced ML methods are crucial for progress.
• Clinical validation is essential to ensure the efficacy, relevance, and cost-effectiveness of AI-driven CKD solutions.